Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Targu Jiu

1 clinical trial in Targu Jiu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Targu Jiu at a glance
1
clinical trial
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 trial in Targu Jiu

Open in trial search
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Targu Jiu

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical research focusing on atherosclerotic cardiovascular disease in patients with end-stage kidney disease. These trials aim to evaluate new therapeutic approaches for managing cardiovascular complications in dialysis patients.

  • Cardiovascular outcomes in ESKD patients
  • Inflammatory biomarker reduction
  • Dialysis-related cardiovascular complications

Studies investigate the relationship between C-reactive protein levels and cardiovascular health in patients undergoing maintenance dialysis, exploring potential therapeutic interventions to improve patient outcomes.

02 Nephrology Studies

Research centered on improving outcomes for patients with end-stage kidney disease through innovative treatment approaches. The trials evaluate specialized medications designed for the dialysis population.

  • ESKD management strategies
  • Dialysis patient care
  • Inflammatory marker monitoring

These studies focus on developing targeted therapies to address the complex medical needs of patients requiring regular dialysis treatment.

03 Inflammation Research

Clinical investigations examining the role of inflammatory markers in cardiovascular complications among dialysis patients. The research explores novel therapeutic agents designed to modulate inflammatory responses.

  • Inflammatory biomarker analysis
  • Anti-inflammatory therapies
  • Cardiovascular risk assessment

The studies aim to understand and address the connection between chronic inflammation and cardiovascular outcomes in the ESKD population.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.